Gastroenterology Doctors in Edison, NJ Accepting Medicare

12 Gastroenterology doctors found. Showing 1 - 12

Dr. Ronald A Shugar, MD Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 98 James St, Suite 104, Edison, NJ 08820 Phone: 732-494-6300    Fax: 732-494-1028

Dr. Marc Rafael Wolfman, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 205 May St, Suite 201, Edison, NJ 08837 Phone: 732-661-9225    Fax: 732-661-9259

Dr. Michael Scott Goldberg, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 205 May St, Suite 201, Edison, NJ 08837 Phone: 732-661-9225    Fax: 732-661-9259

Dr. David Reissman, M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 98 James St, Suite 209, Edison, NJ 08820 Phone: 732-549-9495

Dr. Mayank D Patel, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 659 New Dover Rd, Edison, NJ 08820 Phone: 732-382-0344    Fax: 732-382-0340

Dr. Steven Edward Hodes, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 205 May St, Suite 201, Edison, NJ 08837 Phone: 732-661-9225    Fax: 732-661-9259

Dr. James Penn, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 205 May St Ste 201, Edison, NJ 08837 Phone: 732-661-9228    Fax: 732-661-9259

Dr. Richard A. Medina, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3840 Park Ave, Suite 101, Edison, NJ 08820 Phone: 732-549-4747    Fax: 732-549-6132

Dr. Abdulhadi Quadri, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 8 Sherwood Rd, Edison, NJ 08820 Phone: 609-200-0469

Dr. David Mark Rosenheck, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 205 May St, Suite 201, Edison, NJ 08837 Phone: 732-661-9225    Fax: 732-661-9259

Dr. Scott S Chae, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2 State Route 27, Suite 107, Edison, NJ 08820 Phone: 732-632-9777    Fax: 732-632-8096

Daniel Sedhom, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 205 May St Ste 201, Edison, NJ 08837 Phone: 732-661-9225

News Archive

Advocat second-quarter revenues increase 3.4% to $141.6 million

Advocat Inc. today announced its results for the second quarter and six months ended June 30, 2010. On August 5, 2010 the Company declared a third quarter dividend of 5.5 cents per common share. The dividend will be paid October 14, 2010 to shareholders of record on September 30, 2010.

Scientists find way to boost efficacy of powerful antimalarial drug with anti-cancer medicines

Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

Antares Pharma receives Notice of Allowance for new patent application on reconstitutable drugs

Antares Pharma, Inc. today announced that it has received a Notice of Allowance from the U.S. Patent Office for application 13/584,317. This application, along with U.S. Patent 8,251,947 granted in August of 2012, relate to Antares' injector technology for wet-dry injectable drugs such as lyophilized biologicals or peptide drugs that require dry storage to assure stability.

Black cancer patients better represented in taxpayer-funded clinical trials

Black patients are better represented in taxpayer-funded clinical trials testing new cancer treatments compared to trials run by pharmaceutical companies - although black patients are not fully represented in cancer clinical trials, regardless of sponsor.

Atrix Signs Feasibility Agreement for Development of Two New Compounds

Atrix Laboratories, Inc. has announced today that the company has signed a limited feasibility agreement with Aventis SA (NYSE: AVE) to begin preliminary research on two proprietary Aventis compounds formulated in Atrix's delivery technology, Atrigel®. The current agreement is specific for these compounds in an undisclosed therapeutic area.

Read more Medical News

› Verified 8 days ago